Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Moderate Alzheimer's Disease Treated With Donepezil.

Trial Profile

Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Moderate Alzheimer's Disease Treated With Donepezil.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Apr 2016

At a glance

  • Drugs Idalopirdine (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms LADDER
  • Most Recent Events

    • 11 Apr 2016 Results will be presented at the 2016 American Academy of Neurology (AAN) Annual Meeting, according to a Lundbeck Inc media release.
    • 16 Jul 2013 Results presented at the 2013 Alzheimer's Association International Conference .
    • 16 Jul 2013 Results will be published in Alzheimer's and Dementia: The Journal of the Alzheimer's Association, according to a media release from Lundbeck and Otsuka.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top